FDA says Vertex hepatitis drug is highly effective

April 26, 2011

(AP) -- Federal health officials say a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.

The posted its review of Vertex's telaprevir ahead of a meeting Thursday where outside experts will vote on the benefits of the drug. On Wednesday the experts will review a similar drug from Merck.

Both new drugs work by blocking the enzyme protease, which allows the hepatitis virus to reproduce. The new approach represents a breakthrough from older medicines, which are designed to help the fight hepatitis.

FDA scientists said 79 percent of patients who added telaprevir to older medicines were virus free six months after treatment.

shares

Related Stories

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

neiorah
not rated yet Apr 26, 2011
Great, now the need for liver transplants will go down

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.